Limited impact of pneumococcal vaccines on invasive pneumococcal disease in Nunavik (Quebec)
- 19 October 2018
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Public Health
- Vol. 110 (1) , 36-43
Abstract
In 2002, a mass immunization campaign using the 23-valent pneumococcal polysaccharide vaccine (PPV23) was carried out in Nunavik to control an outbreak caused by a virulent clone of serotype 1 Streptococcus pneumoniae. At the same time, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine immunization of infants, replaced by the 10-valent vaccine (PCV10) in 2009, and the 13-valent vaccine (PCV13) in 2011. The objective of this study was to describe the epidemiology of invasive pneumococcal disease (IPD) in relation to pneumococcal vaccine use.Keywords
This publication has 23 references indexed in Scilit:
- Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adultsClinical Microbiology and Infection, 2013
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLOS Medicine, 2013
- Invasive Pneumococcal Disease in Alaskan ChildrenThe Pediatric Infectious Disease Journal, 2010
- Invasive Bacterial Diseases in Northern CanadaEmerging Infectious Diseases, 2008
- Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adultsVaccine, 2007
- Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control studyThe Lancet, 2006
- Impact of a mass immunization campaign to cotrol an outbreak of severe respiratory infections in Nunavik, northern CanadaInternational Journal of Circumpolar Health, 2006
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991